Peru Retention Samples, Shelf Life and Distribution Transport: R.M. N° 937-2014/MINSA Compliance

Regulatory information verified as of October 29, 2026

1. Key takeaways

Three requirements in Peru that appear scattered, the retention sample quantities, the shelf life declaration, and the distribution and transport validation, are in compliance terms three links of a single chain of evidence. R.M. N° 937-2014/MINSA, published on 2014-12-03, sets the list of retention sample quantities for pharmaceutical products and medical devices. The Good Distribution and Transport Practices manual, the Buenas Prácticas de Distribución y Transporte or BPD, of R.M. N° 833-2015/MINSA, published on 2015-12-23, governs the transport stage. The Good Storage Practices manual, the Buenas Prácticas de Almacenamiento or BPA, of R.M. N° 132-2015/MINSA, published on 2015-03-02, governs the warehousing stage. When the three fail to connect, the shelf life conclusion that holds in the registration file no longer holds in the market.

2. Legal basis

Regulatory information verified as of October 29, 2026.

3. Expert insights

Insight 1: The purpose of retention samples is retesting in a dispute, and the quantity list answers whether the sample is sufficient to find a problem.

R.M. N° 937-2014/MINSA lists the retention quantities by product. Its technical meaning is that when a batch is questioned or an adverse event occurs, a sufficient, traceable quantity of samples from the same batch, held under the prescribed conditions, must be available for retesting. The key to retention sample management is therefore not having samples but three things: the samples come from registered batches, the quantities meet the list, and the storage and transport conditions claimed on the label are maintained throughout the retention period. Running retention samples as commercial stock or as demonstration units provides no evidentiary value in a retesting exercise.

Insight 2: Shelf life is a conclusion bound to conditions, not a date printed on the label.

The shelf life in the registration file rests on stability data, and stability data are obtained under specific temperature, humidity, and packaging conditions. When the BPA manual of R.M. N° 132-2015/MINSA or the BPD manual of R.M. N° 833-2015/MINSA is degraded in execution, through cold chain interruptions, warehouse temperature excursions, or transport durations beyond the validated range, the expiry date on the label ceases to hold scientifically. This is why the storage and transport conditions must be written consistently in three places: in the explanations of the technical report, item 4 of Class I, in the mandatory label elements, and in the storage and handling chapter of the IFU. Only with all three aligned can the company prove after the fact that the conditions were defined at all.

Insight 3: The interface between the registration stage and the distribution stage is the pair of registration holder and distribution entity.

The sanitary registration is held by the registration holder, the Titular del Registro Sanitario, also called the Peru Registration Holder or PRH, while the obligations of warehousing, distribution, and transport fall on wholesale distributors, Droguerías, or laboratories holding a sanitary operating authorization. D.S. N° 014-2011-SA, published on 2011-07-27, fixes the establishment and authorization framework for such entities, and the BPA and BPD manuals set their operating requirements. Mechanically, the registration holder carries the organizational responsibility for continued compliance, including ensuring that the actual storage and transport chain matches the conditions declared in the registration. The largest problem created by the separation of subjects is that the conditions written in the registration file are never communicated to the warehouse, producing the state of a correct certificate with an out-of-bounds warehouse.

Insight 4: The combination of the 5-year validity and the re-registration window sets the update rhythm for retention samples and stability data.

The sanitary registration under D.S. N° 016-2011-SA is valid for 5 years, and re-registration may be filed 1 year before expiry under Article 7. Placing the extension of stability data, the continuation of retention batches, and the re-registration window on one timetable avoids the gap where the registration still stands but the evidence has grown old.

4. Practical recommendations

1. Build a retention sample ledger against the list of R.M. N° 937-2014/MINSA, registering batches, quantities, and storage conditions.
2. Keep retention sample storage conditions identical to the label claims and record them continuously.
3. Align the label expiry date, the stability data, and the IFU storage chapter on one basis before submission.
4. For cold chain devices, execute storage and transport under the manuals of R.M. N° 132-2015/MINSA and R.M. N° 833-2015/MINSA and retain temperature records.
5. Have the registration holder pass the registered storage and transport conditions in writing to the actual warehouse and transport operators, keeping confirmation records.
6. Plan stability study extensions and retention batch continuation around the axis of the 5 years validity and the re-registration window opening 1 year before expiry.

5. Verification checklist

□ Retention quantities have been determined against the list of R.M. N° 937-2014/MINSA and registered by batch

□ Retention storage conditions match the label claims and have continuous records

□ Label expiry date, stability data, and IFU storage chapter are aligned on one basis

□ The warehousing stage meets the BPA manual of R.M. N° 132-2015/MINSA

□ The transport stage meets the BPD manual of R.M. N° 833-2015/MINSA, with complete cold chain temperature records

□ The registration holder has passed the storage and transport conditions to the distribution entities in writing, with confirmations retained

□ Stability extensions and retention continuation are scheduled against the 5 years validity and the 1 year re-registration window

Regulatory information verified as of October 29, 2026.

*GRZAN Regulatory Team*

GRZAN provides medical device registration support in Peru for manufacturers, importers, and authorized representatives, covering retention sample systems, distribution and transport compliance, and re-registration planning. For inquiries, contact info@grzanglobal.com.